Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03204955 · ClinicalTrials.gov registry record · Phase 1
A Low ChloridE hyperTonic Solution for Brain Edema
A Phase 1 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 1
- Development phase
- 59
- Enrollment target
NCT03204955 is a Phase 1 study that has completed, run by Emory University. The registered enrollment target is 59 participants.
The verdict
NCT03204955, a Phase 1 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 59 participants
- Enrollment target
Study Summary
This pilot study will compare the two hypertonic solutions currently used for subarachnoid hemorrhage (SAH) - related complications and to determine if the reduction of chloride load is safer, and as efficacious as the classic hypertonic solution.
Interventions
- DRUG Sodium chloride /sodium acetate (16.4%)
- DRUG Sodium chloride (23.4%)
- DRUG PlasmaLyte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2017-06-28 |
| Est. Completion | 2018-09-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03204955
The ClinicalTrials.gov registry entry for NCT03204955 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Sodium chloride /sodium acetate (16.4%) is the first listed.
NCT03204955 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03204955 about?
NCT03204955 is a clinical study titled "A Low ChloridE hyperTonic Solution for Brain Edema". This pilot study will compare the two hypertonic solutions currently used for subarachnoid hemorrhage (SAH) - related complications and to determine if the reduction of chloride load is safer, and as efficacious as the classic hypertonic solution.
What is the current status of trial NCT03204955?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 59 participants. The study started on 2017-06-28. Estimated completion is 2018-09-30.
What interventions are being tested in trial NCT03204955?
The interventions under investigation include: Sodium chloride /sodium acetate (16.4%) (DRUG), Sodium chloride (23.4%) (DRUG), PlasmaLyte (DRUG).
Who is sponsoring clinical trial NCT03204955?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.